C-2 MODIFIED ERYTHROMYCIN DERIVATIVES

A compound having the formula selected from the group consisting of a compound of formula (I), a compound of formula (II), and a compound of formula (III) as well as pharmaceutically acceptable salts, esters, solvates, metabolites, and prodrugs thereof, are useful in treating bacterial infections. A...

Full description

Saved in:
Bibliographic Details
Main Author SUOMING, ZHANG
Format Patent
LanguageEnglish
Spanish
Published 30.07.2002
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A compound having the formula selected from the group consisting of a compound of formula (I), a compound of formula (II), and a compound of formula (III) as well as pharmaceutically acceptable salts, esters, solvates, metabolites, and prodrugs thereof, are useful in treating bacterial infections. Also provided are pharmaceutically acceptable compositions, methods of treating bacterial infections, and processes for the preparation of the compounds. Se describe un compuesto que tiene la formula seleccionada del grupo que consiste de un compuesto de la formula (I), un compuesto de la formula (II) y un compuesto de la formula (III) asi como sales farmaceuticamente aceptables, esteres, solvatos, metabolitos y sus profarmacos, utiles para el tratamiento de infecciones bacterianas. Tambien se proporcionan composiciones farmaceuticamente aceptables, metodos para tratar infecciones bacterianas, y procedimientos para la preparacion de los compuestos. (Ver Formula).
AbstractList A compound having the formula selected from the group consisting of a compound of formula (I), a compound of formula (II), and a compound of formula (III) as well as pharmaceutically acceptable salts, esters, solvates, metabolites, and prodrugs thereof, are useful in treating bacterial infections. Also provided are pharmaceutically acceptable compositions, methods of treating bacterial infections, and processes for the preparation of the compounds. Se describe un compuesto que tiene la formula seleccionada del grupo que consiste de un compuesto de la formula (I), un compuesto de la formula (II) y un compuesto de la formula (III) asi como sales farmaceuticamente aceptables, esteres, solvatos, metabolitos y sus profarmacos, utiles para el tratamiento de infecciones bacterianas. Tambien se proporcionan composiciones farmaceuticamente aceptables, metodos para tratar infecciones bacterianas, y procedimientos para la preparacion de los compuestos. (Ver Formula).
Author SUOMING, ZHANG
Author_xml – fullname: SUOMING, ZHANG
BookMark eNrjYmDJy89L5WRQddY1UvD1d_F083R1UXANigzxCPL3jXT29FNwcQ3yDHMM8QxzDeZhYE1LzClO5YXS3AxKbq4hzh66qQX58anFBYnJqXmpJfG-EQGOBoYGhoZmxsaOxkQpAgDOvSXK
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DERIVADOS DE ERITROMICINA MODIFICADA CON C-2.
Edition 7
ExternalDocumentID MXPA01011633A
GroupedDBID EVB
ID FETCH-epo_espacenet_MXPA01011633A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:19:48 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_MXPA01011633A3
Notes Application Number: MX2001PA11633
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020730&DB=EPODOC&CC=MX&NR=PA01011633A
ParticipantIDs epo_espacenet_MXPA01011633A
PublicationCentury 2000
PublicationDate 20020730
PublicationDateYYYYMMDD 2002-07-30
PublicationDate_xml – month: 07
  year: 2002
  text: 20020730
  day: 30
PublicationDecade 2000
PublicationYear 2002
RelatedCompanies ABBOTT LABORATORIES
RelatedCompanies_xml – name: ABBOTT LABORATORIES
Score 2.4418545
Snippet A compound having the formula selected from the group consisting of a compound of formula (I), a compound of formula (II), and a compound of formula (III) as...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SUGARS
Title C-2 MODIFIED ERYTHROMYCIN DERIVATIVES
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020730&DB=EPODOC&locale=&CC=MX&NR=PA01011633A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8QwEB7WVdSbroq6KkW0t2LpI8VDkW7S0gp9UGvpnpY-siCCLrbi33catrqnvYUEJs_JzJfMA-CO1JqOO1spvC4RoFhGrVSWypUKZTMnS1SQRUihMCL-q_FcmMUI3gdfGBEn9EcER0SOqpHfO3Ffr_4fsZiwrWwfqjes-nzyMpvJAzrW-hMrs5ntJjGLqUypHRZylNqJ0wdTQ-VDd3ZgF_Voq7f_cvNZ75ay2pQp3hHsJUjuozuGEW8ncECH1GsT2A_XP95YXDNfewL3VNGkMGaBF7hMctN55qdxOKdBJDGEY7mTBbn7cgq3nptRX8H-Fn-zW4TFxtj0Mxgj7OfnIBGzTyRFGg3hrlE2jyUqYzpXCdcsYtYNv4DpFkKXW1uncCiymvRvlOoVjLuvb36NwrWrbsSi_AImA3ku
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTmU6P4po34qlXTN9KNIlLa0u7Zh1dE9l7SKIoMNV_Pe9hFX3tLeQQL4vd79L8juAa1JaNq5sYYhyhgCl3yuNom8Ko0DdLMgrGsiKUojHJHzpPWZO1oD3-i-M4gn9UeSIKFElynulzuvFvxOLqbeVy9viDbM-H4LUZXqNji25Y3U2cP1RwhKqU-ryTI_H7siTZGpofNjeFmyjjX0nifb9yUB-S1ms65RgH3ZGWN1HdQANsWxDi9ah19qwy1c33phcCd_yEG6oYWk8YVEQ-Uzzx9M0HCd8SqNYYwjHJl4aTfznI7gK_JSGBraX_40u59la3-xjaCLsFx3QiCMDSZG5hXC3N5vfz9AYs4VJhNUnTjkXJ9DdUNHpxtJLaIUpH-bDKH7qwp6KcCL9leYZNKuvb3GOirYqLtQE_QL8Ynwe
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=C-2+MODIFIED+ERYTHROMYCIN+DERIVATIVES&rft.inventor=SUOMING%2C+ZHANG&rft.date=2002-07-30&rft.externalDBID=A&rft.externalDocID=MXPA01011633A